12-10-2021, 01:45 PM
A bit of a disappointment from Abbott Labs. Apparently, the analyst expectations for negative 7% EPS growth in 2022 must have some merit.
Abbott Laboratories (NYSE:ABT) declares $0.47/share quarterly dividend, 4.4% increase from prior dividend of $0.45.
Forward yield 1.41%
Payable Feb. 15; for shareholders of record Jan. 14; ex-div Jan. 13.
Abbott Laboratories (NYSE:ABT) declares $0.47/share quarterly dividend, 4.4% increase from prior dividend of $0.45.
Forward yield 1.41%
Payable Feb. 15; for shareholders of record Jan. 14; ex-div Jan. 13.